Abstract BackgroundIn Canada, the majority of HIV-positive pregnant women receive combination antiretroviral therapy that includes a ritonavir-boosted protease inhibitor to prevent mother-to-child HIV transmission. However, protease inhibitor-based combination antiretroviral therapy has been associated with increased rates of preterm, low birth weight, and small for gestational age births. Our previous experimental findings demonstrate that protease inhibitor use during pregnancy is associated with decreased progesterone levels that correlate with fetal growth, and that progesterone supplementation can improve protease inhibitor-induced fetal growth restriction. We hypothesize that HIV-positive pregnant women who receive protease inhibitor-based combination therapy may also benefit from progesterone supplementation during pregnancy. Methods/designIn order to test this hypothesis, we have designed an open-label, multi-centre, randomized controlled (parallel group) pilot trial. The initial goal of this trial is to test feasibility and acceptability of our intervention. Forty HIV-positive pregnant women who are either on, or intending to start or switch to a boosted protease inhibitor-based combination antiretroviral regimen will be enrolled from six sites across Ontario, Canada. Twenty-five women will be randomized to self-administer natural progesterone (Prometrium, 200Â mg) vaginally every night starting between gestational week 16 and 24 until week 36, and 15 women will be randomized to no intervention. While the participants and treating physicians will not be blinded, the laboratory personnel performing the biochemical and morphological evaluations will be blinded to ensure unbiased evaluation. The primary outcome of the pilot study is the feasibility of enrolment as measured by the recruitment rate and patient-reported reasons to decline participation. Secondary outcomes in participants include safety, acceptability, and adherence to progesterone supplementation. DiscussionGiven the safety of intravaginal progesterone and its current use in the general obstetrical population to prevent recurrent preterm delivery, this pilot study will provide data to determine the feasibility of a larger randomized controlled trial to assess the impact of this intervention on improving neonatal health in the context of HIV-positive pregnancies. Trial registrationClinicalTrials.gov, NCT02400021
Prometrium          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Progesterone          

safety                        0.9586958200121344^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Safety                

Canada                        0.9999999937429038^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Canada                

progesterone                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Progesterone          

progesterone                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Progesterone          

fetal growth                  0.9501086953131664^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Gestational_age       

gestational age               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gestational_age       

antiretroviral therapy        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Management_of_HIV/AIDS

protease                      0.9999999999965894^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protease_inhibitor_(pharmacology)

protease                      0.9999999999965894^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protease_inhibitor_(pharmacology)

pregnancy                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pregnancy             

antiretroviral                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Management_of_HIV/AIDS

open-label                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Open-label_trial      

health                        0.9945896358428833^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Health                

HIV-positive                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/HIV                   

protease inhibitor            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Protease_inhibitor_(pharmacology)

HIV                           0.9999999999745341^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/HIV                   

progesterone                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Progesterone          

pilot study                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pilot_experiment      

safety                        0.9586958200121344^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Safety                

transmission                  0.9999999786964511^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Transmission_(medicine)

biochemical                   0.9999999782742182^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Biochemistry          

neonatal                      0.7457765282956907^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Infant                

unbiased                      0.5374226032361293^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Bias                  

protease                      0.9999999999965894^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protease_inhibitor_(pharmacology)

laboratory                    0.9377958829961359^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Laboratory            

HIV-positive                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/HIV                   

progesterone                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Progesterone          

randomized controlled trial   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Randomized_controlled_trial

antiretroviral therapy        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Management_of_HIV/AIDS

preterm                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Preterm_birth         

HIV-positive                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/HIV                   

obstetrical                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Obstetrics            

progesterone                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Progesterone          

preterm delivery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Preterm_birth         

combination therapy           0.9999999982039753^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Management_of_HIV/AIDS

HIV-positive                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/HIV                   

physicians                    0.754079533355077^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Health_care_provider  

protease inhibitor            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Protease_inhibitor_(pharmacology)

pregnancy                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pregnancy             

Canada                        0.9999999937429038^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Canada                

morphological                 0.9999344909950573^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Morphology_(biology)  

pilot                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pilot_experiment      

fetal growth restriction      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intrauterine_growth_restriction

pregnancies                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pregnancy             

hypothesis                    0.9999999994959126^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hypothesis            

Ontario                       0.9026358897708188^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ontario               

progesterone                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Progesterone          

birth weight                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Birth_weight          

pilot study                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pilot_experiment      

vaginally                     0.9987243634513017^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Childbirth            

protease                      0.9999999999965894^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protease_inhibitor_(pharmacology)

